3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
15
Vitamin D Deficiency
13
Prostatic Neoplasms
13
Polycystic Ovary Syndrome
8
Neoplasms
7
Osteoporosis
4
Colorectal Neoplasms
4
Warts
3
Rectal Neoplasms
3
Ovarian Neoplasms
3
Myelodysplastic Syndromes
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Colonic Neoplasms
3
Brain Neoplasms
3
Male Urogenital Diseases
2
Leukemia
2
Cardiovascular Diseases
2
Adenomatous Polyps
2
Stroke
1
Spinal Cord Injuries
1
Skin Neoplasms
1
Seizures
1
Psoriasis
1
Prostate Adenocarcinoma
1
Premature Birth
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polyps
1
Pathologic Processes
1
Pain
1
Osteoarthritis
1
Interventions
Etanercept
7
tofacitinib
6
Adalimumab
4
Methotrexate
3
secukinumab
2
sotrastaurin
1
sodium luminolate
1
purine
1
ixekizumab
1
fumaric acid
1
calcipotriene
1
baricitinib
1
apremilast
1
Vitamin D
1
Vaccines
1
Sulfasalazine
1
Saline Solution
1
Mesalamine
1
Mercaptopurine
1
Infliximab
1
Herpes Zoster Vaccine
1
Folic Acid
1
Fish Oils
1
Fatty Acids, Omega-3
1
Eicosapentaenoic Acid
1
Eating
1
Docosahexaenoic Acids
1
Cholecalciferol
1
Biopsy
1
Anti-Infective Agents, Local
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Psoriasis
×
Cholecalciferol
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts